Sponsor:
Jasper Therapeutics, Inc.
Code:
NCT04429191
Conditions
MYELODYSPLASTIC SYNDROME; MDS
ACUTE MYELOID LEUKEMIA; AML
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Humanized anti-CD117 Monoclonal Antibody (JSP191)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations